YABAO PHARM.CORP released its semi-annual performance, with a net profit attributable to the parent company of 174 million yuan, a year-on-year decrease of 2.99%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, YABAO PHARM.CORP disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.139 billion yuan, a year-on-year decrease of 21.08%; the net profit attributable to shareholders of the listed company was 174 million yuan, a year-on-year decrease of 2.99%; the net profit excluding non-recurring gains and losses was 160 million yuan, a year-on-year decrease of 1.69%; the basic earnings per share were 0.2483 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments